Good news! China approved clinical trials for two types of inactivated #vaccines for #COVID_19 on Tuesday.

China has approved early-stage human tests for two experimental coronavirus vaccines as it battles to contain imported cases and prevent a second wave of COVID-19. 

The experimental vaccines are being developed by a Beijing-based unit of Sinovac Biotech and by the Wuhan Institute of Biological Products, an affiliate of state-owned China National Pharmaceutical Group, state news agency Xinhua reported on Tuesday.